Basic Information
Neulastim Pre-filled Syringe 6mg/0.6ml
INJECTION, SOLUTION
Regulatory Information
SIN13200P
April 20, 2006
Prescription Only
Therapeutic
SUBCUTANEOUS
August 10, 2023
June 4, 2025
XL03AA13
Company Information
AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD
AMGEN BIOTECHNOLOGY SINGAPORE PTE LTD
Active Ingredients
Pegfilgrastim
Strength: 6mg/0.6ml
Detailed Information
Contraindications
**2.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section 1.5 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
Indication Information
**2.1 Therapeutic Indication(s)** Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).